403 related articles for article (PubMed ID: 31183778)
1. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
2. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
3. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
4. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
5. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
[TBL] [Abstract][Full Text] [Related]
6. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
9. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
10. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
11. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC.
Ding N; Pang Z; Zhang X; Huang C; Yang Y; Liu Q; Du J
Sci Rep; 2017 Apr; 7(1):584. PubMed ID: 28373661
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
15. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
[No Abstract] [Full Text] [Related]
16. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.
Liu H; Yan T; Zhang T; Chen X; Wang Y; Du J
Medicine (Baltimore); 2019 May; 98(20):e15645. PubMed ID: 31096486
[TBL] [Abstract][Full Text] [Related]
17. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy.
Dehing-Oberije C; De Ruysscher D; van der Weide H; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Simons J; Teule J; Rahmy A; Thimister P; Steck H; Lambin P
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1039-44. PubMed ID: 17889446
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.
Wang Q; Wang S; Sun Z; Cao M; Zhao X
BMC Cancer; 2022 Jul; 22(1):801. PubMed ID: 35858848
[TBL] [Abstract][Full Text] [Related]
19. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
20. Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study.
Shang X; Li Z; Lin J; Yu H; Zhao C; Wang H; Sun J
J Oncol; 2020; 2020():1087237. PubMed ID: 33381175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
